GTC Biotherapeutics (fka GTCB)

[OKY]

DEW
“being run by LEO, has been slower than planned being run by LEO, has been slower than planned”

“reprioritization by LEO, GTC has entered into negotiations for the transition of the program for commercialization and clinical development for Europe and the Middle East from LEO Pharma to LFB”

Due, I’m not strong with language and I also bend things some times to fit my thinking but saying Leo in effect was dragging along and they (GTC) was anxious to move on, it sounded to me like GTC was not happy and that’s why Leo backed out. I interpreted this through the lens of TOM’S response to me, which I posted here.

I think there is a case that can be made. It’s a matter of interpreting who had what effect on whom. A stretch?